Fingerprint
Dive into the research topics where Yoshinobu Maeda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cytomegalovirus reactivation in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
Hayashino, K., Seike, K., Masunari, T., Hashida, R., Oka, S., Fujiwara, Y., Terao, T., Kitamura, W., Kobayashi, H., Kamoi, C., Kondo, T., Fujiwara, H., Asada, N., Ennishi, D., Fujii, K., Fujii, N. & Maeda, Y., Nov 2025, In: International journal of hematology. 122, 5, p. 689-699 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
High Antigenicity for Treg Cells Confers Resistance to PD-1 Blockade Therapy via High PD-1 Expression in Treg Cells
Matsuura, H., Ishino, T., Ninomiya, T., Ninomiya, K., Tachibana, K., Honobe-Tabuchi, A., Muto, Y., Inozume, T., Ueda, Y., Ohashi, K., Maeda, Y., Nagasaki, J. & Togashi, Y., May 2025, In: Cancer Science. 116, 5, p. 1214-1226 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
High Prevalence of MYD88 and CD79B Mutations in Primary Sinonasal Diffuse Large B-Cell Lymphoma
Peng, F., Igawa, T., Urata, T., Kobayashi, H., Isoda, T., Ono, S., Tanaka, T., Ennisshi, D., Maeda, Y. & Yamamoto, H., Feb 2025, In: Hepatology. 49, 2, p. 159-168 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Activated CD4+ T Cell Proportion in the Peripheral Blood Correlates with the Duration of Cytokine Release Syndrome and Predicts Clinical Outcome after Chimeric Antigen Receptor T Cell Therapy
Kitamura, W., Asada, N., Ikegawa, S., Fujiwara, H., Kamoi, C., Ennishi, D., Nishimori, H., Fujii, K., Fujii, N., Matsuoka, K. I. & Maeda, Y., 2024, In: Internal Medicine. 63, 13, p. 1863-1872 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHD
Inamoto, Y., Kato, K., Kawakita, T., Onishi, Y., Matsuoka, K. I., Shiratori, S., Ikegame, K., Hiramoto, N., Toyosaki, M., Katayama, Y., Murayama, S., Sasagawa, Y., Maeda, Y., Hatake, K. & Teshima, T., Oct 2024, In: American Journal of Hematology. 99, 10, p. 1917-1926 10 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Link opens in a new tab Citations (Scopus)